(2006) conducted a randomized placebo-controlled
augmentation trial utilizing osmotic-release oral system (OROS)-
Methylphenidate a long-acting methylphenidate at once a day
doses of 18 to 54 mg/day added to a standard antidepressant
therapy over 4 weeks in sixty depressed individuals.